Submission Details
| 510(k) Number | K191868 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 12, 2019 |
| Decision Date | March 31, 2020 |
| Days to Decision | 263 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K191868 is an FDA 510(k) clearance for the iCEWav Neuromonitoring Platform, a Full-montage Standard Electroencephalograph (Class II — Special Controls, product code GWQ), submitted by Ice Neurosystems, Inc. (Washington, US). The FDA issued a Cleared decision on March 31, 2020, 263 days after receiving the submission on July 12, 2019. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1400.
| 510(k) Number | K191868 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 12, 2019 |
| Decision Date | March 31, 2020 |
| Days to Decision | 263 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GWQ — Full-montage Standard Electroencephalograph |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1400 |
| Definition | Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations |